Chromosome segregation and genomic stability

Current Opinion in Genetics and Development

Volumn 14, Issue 2, 2004, Pages 120-125

  Draviam, Viji M ^a   Xie, Stephanie ^a   Sorger, Peter K ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Adenomatous polyposis coli; APC; Chromosomal instability; CIN; Hereditary nonpoylposis colorectal cancer; HNPCC; Microsatellite instability; MIN; Mismatch repair; MMR; TSG; Tumor suppressor gene

Indexed keywords

BRCA2 PROTEIN; BUB1 RELATED PROTEIN; BUB3 PROTEIN; PROTEIN MAD1; PROTEIN MAD2; SURVIVIN;

CHROMOSOME SEGREGATION; COLON POLYPOSIS; COLORECTAL CANCER; DNA DAMAGE; GENE DELETION; GENETIC STABILITY; GENOME; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE PROTEINS; CHROMOSOME SEGREGATION; DNA DAMAGE; GENOMIC INSTABILITY; HUMANS; MITOTIC SPINDLE APPARATUS; NEOPLASMS;

EID: 1942471699     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2004.02.007     Document Type: Review

References (62)

1. Hansemann D. Ueber asymmetrische Zelltheilung in epithel Krebsen und deren biologische Bedeutung. Virschows Arch Pathol Anat. 119:1890;299-326. [Title translation: On asymmetric cell divisions in epithelial cancers and their biological significance.].
2. Pellman D. Cancer. A CINtillating new job for the APC tumor suppressor. Science. 291:2001;2555-2556.
3. Boveri T: Zur Frage der Entstehung maligner Tumoren. Jena: Fischer Verlag (English translation by Williams and Wilikins, Baltimore); 1914. [Title translation: On the problem of the origin of malignant tumors.]
4. Stoler D.L., Chen N., Basik M., Kahlenberg M.S., Rodriguez-Bigas M.A., Petrelli N.J., Anderson G.R. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci USA. 96:1999;15121-15126.
5. Nowell P.C. The clonal evolution of tumor cell populations. Science. 194:1976;23-28.
6. Baranovskaya S., Soto J.L., Perucho M., Malkhosyan S.R. Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotype. Proc Natl Acad Sci USA. 98:2001;15107-15112.
7. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instability in colorectal cancers. Nature. 386:1997;623-627.
8. Masuda A., Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene. 21:2002;6684-6697.
9. Nowak M.A., Komarova N.L., Sengupta A., Jallepalli P.V., Shih Ie M., Vogelstein B., Lengauer C. The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA. 99:2002;16226-16231 The authors developed a mathematical model for studying the effect of CIN on the evolutionary dynamics of colorectal tumors in either the presence or absence of an APC mutation. They calculate the conditions required for CIN to initiate tumorigenesis before the mutation of tumor suppressor genes and suggest that an event creating genetic instability is sufficient to initiate and drive tumor progression in sporadic neoplasias.
10. Duesberg P., Li R. Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle. 2:2003;202-210 The authors discuss the various driving forces of tumorigenesis and propose that the inherent instability of aneuploid karyotypes, which is induced either by a carcinogen or spontaneously, is sufficient for tumor formation.
11. Haigis K.M., Caya J.G., Reichelderfer M., Dove W.F. Intestinal adenomas can develop with a stable karyotype and stable microsatellites. Proc Natl Acad Sci USA. 99:2002;8927-8931.
12. Christmann M., Tomicic M.T., Roos W.P., Kaina B. Mechanisms of human DNA repair: an update. Toxicology. 193:2003;3-34.
13. Narayan S., Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer. 2:2003;41.
14. Wei K., Kucherlapati R., Edelmann W. Mouse models for human DNA mismatch-repair gene defects. Trends Mol Med. 8:2002;346-353.
15. Yu H. Regulation of APC-Cdc20 by the spindle checkpoint. Curr Opin Cell Biol. 14:2002;706-714.
16. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer. 2:2002;815-825.
17. Carmena M., Earnshaw W.C. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol. 4:2003;842-854 A comprehensive review of the recent molecular evidence suggesting roles for Aurora A and Aurora B in tumorigenesis.
18. Babu J.R., Jeganathan K.B., Baker D.J., Wu X., Kang-Decker N., van Deursen J.M. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol. 160:2003;341-353 The first instance wherein more than one spindle checkpoint protein has been genetically deleted and the impact of such mutation examined in mice. The authors conclude a synergistic role for Rae1 and Bub3 in tumor formation upon exposure to a carcinogen.
19. Mollinedo F., Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis. 8:2003;413-450 This review on microtubule-interfering agents used in chemotherapy presents information about the chemistry of the drugs as well as the biological processes targeted by them that lead to apoptosis in cancer cells.
20. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K., Markowitz S.D., Kinzler K.W., Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature. 392:1998;300-303.
21. Taylor S.S., Ha E., McKeon F. The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase. J Cell Biol. 142:1998;1-11.
22. Tighe A., Johnson V.L., Albertella M., Taylor S.S. Aneuploid colon cancer cells have a robust spindle checkpoint. EMBO Rep. 2:2001;609-614.
23. Kasai T., Iwanaga Y., Iha H., Jeang K.T. Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors. J Biol Chem. 277:2002;5187-5193.
24. Gupta A., Inaba S., Wong O.K., Fang G., Liu J. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene. 22:2003;7593-7599.
25. Dobles M., Liberal V., Scott M.L., Benezra R., Sorger P.K. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell. 101:2000;635-645.
26. Wang Q., Liu T., Fang Y., Xie S., Huang X., Mahmood R., Ramasiwamy G., Sakamoto K.M., Darzynkiewicz Z., Xu M.et al. BUBR1-deficiency results in abnormal megakaryopoiesis. Blood. 103:2004;1278-1285 This study demonstrates along with [25] that mutation of the spindle checkpoint components leads to tissue-specific lesions in mice, suggesting that distinct checkpoint mutations may promote different tumor spectrum.
27. Putkey F.R., Cramer T., Morphew M.K., Silk A.D., Johnson R.S., McIntosh J.R., Cleveland D.W. Unstable kinetochore-microtubule capture and chromosomal instability following deletion of CENP-E. Dev Cell. 3:2002;351-365 Using a conditional mouse model, the authors demonstrate that selective deletion of CENP-E in chemically damaged liver cells cause aberrant mitoses marked by chromosome missegregation suggesting CENP-E's role in CIN.
28. Michel L.S., Liberal V., Chatterjee A., Kirchwegger R., Pasche B., Gerald W., Dobles M., Sorger P.K., Murty V.V., Benezra R. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature. 409:2001;355-359.
29. Miyoshi Y., Iwao K., Egawa C., Noguchi S. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer. 92:2001;370-373.
30. Jiang Y., Zhang Y., Lees E., Seghezzi W. AuroraA overexpression overrides the mitotic spindle checkpoint triggered by nocodazole, a microtubule destabilizer. Oncogene. 22:2003;8293-8301.
31. Kaplan K.B., Burds A.A., Swedlow J.R., Bekir S.S., Sorger P.K., Nathke I.S. A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nat Cell Biol. 3:2001;429-432.
32. Green R.A., Kaplan K.B. Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC. J Cell Biol. 163:2003;949-961 By introducing a single truncating mutation in APC, similar to mutations found in tumor cells, the authors illustrate that a tumor-promoting APC mutant can dominantly cause a dramatic increase in chromosome-segregation defects.
33. Sieber O.M., Heinimann K., Gorman P., Lamlum H., Crabtree M., Simpson C.A., Davies D., Neale K., Hodgson S.V., Roylance R.R.et al. Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc Natl Acad Sci USA. 99:2002;16910-16915.
34. Spencer F., Gerring S.L., Connelly C., Hieter P. Mitotic chromosome transmission fidelity mutants in Saccharomyces cerevisiae. Genetics. 124:1990;237-249.
35. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene. 21:2002;8981-8993.
36. Lee H., Trainer A.H., Friedman L.S., Thistlethwaite F.C., Evans M.J., Ponder B.A., Venkitaraman A.R. Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2. Mol Cell. 4:1999;1-10.
37. Futamura M., Arakawa H., Matsuda K., Katagiri T., Saji S., Miki Y., Nakamura Y. Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1. Cancer Res. 60:2000;1531-1535.
38. Lee M., Daniels M.J., Venkitaraman A.R. Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression. Oncogene. 23:2004;865-872.
39. Su L.K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A.R., Luongo C., Gould K.A., Dove W.F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science. 256:1992;668-670.
40. Rask K., Nilsson A., Brannstrom M., Carlsson P., Hellberg P., Janson P.O., Hedin L., Sundfeldt K. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta. Br J Cancer. 89:2003;1298-1304.
41. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 3:1997;917-921.
42. Temme A., Rieger M., Reber F., Lindemann D., Weigle B., Diestelkoetter-Bachert P., Ehninger G., Tatsuka M., Terada Y., Rieber E.P. Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell. Mol Biol Cell. 14:2003;78-92.
43. Uren A.G., Wong L., Pakusch M., Fowler K.J., Burrows F.J., Vaux D.L., Choo K.H. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol. 10:2000;1319-1328.
44. Charrasse S., Mazel M., Taviaux S., Berta P., Chow T., Larroque C. Characterization of the cDNA and pattern of expression of a new gene over-expressed in human hepatomas and colonic tumors. Eur J Biochem. 234:1995;406-413.
45. Gergely F., Draviam V.M., Raff J.W. The ch-TOG/XMAP215 protein is essential for spindle pole organization in human somatic cells. Genes Dev. 17:2003;336-341.
46. Chen Y., Riley D.J., Chen P.L., Lee W.H. HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis. Mol Cell Biol. 17:1997;6049-6056.
47. Saez C., Japon M.A., Ramos-Morales F., Romero F., Segura D.I., Tortolero M., Pintor-Toro J.A. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene. 18:1999;5473-5476.
48. Pei L., Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol. 11:1997;433-441.
49. Yu R., Lu W., Chen J., McCabe C.J., Melmed S. Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology. 144:2003;4991-4998.
50. Mei J., Huang X., Zhang P. Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts. Curr Biol. 11:2001;1197-1201.
51. Adams R.R., Eckley D.M., Vagnarelli P., Wheatley S.P., Gerloff D.L., Mackay A.M., Svingen P.A., Kaufmann S.H., Earnshaw W.C. Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells. Chromosoma. 110:2001;65-74.
52. Cutts S.M., Fowler K.J., Kile B.T., Hii L.L., O'Dowd R.A., Hudson D.F., Saffery R., Kalitsis P., Earle E., Choo K.H. Defective chromosome segregation, microtubule bundling and nuclear bridging in inner centromere protein gene (Incenp)-disrupted mice. Hum Mol Genet. 8:1999;1145-1155.
53. Takahashi T., Sano B., Nagata T., Kato H., Sugiyama Y., Kunieda K., Kimura M., Okano Y., Saji S. Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Sci. 94:2003;148-152.
54. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., Schryver B., Flanagan P., Clairvoyant F., Ginther C.et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17:1998;3052-3065.
55. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., Brinkley B.R., Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 20:1998;189-193.
56. Anand S., Penrhyn-Lowe S., Venkitaraman A.R. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell. 3:2003;51-62.
57. Ewart-Toland A., Briassouli P., de Koning J.P., Mao J.H., Yuan J., Chan F., MacCarthy-Morrogh L., Ponder B.A., Nagase H., Burn J.et al. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet. 34:2003;403-412 The authors refine the localization of a tumor susceptibility locus to a region of 1-2Mb on chromosome 2 using mouse genetics and further resolve to the level of individual genes by correlative study of an orthologous locus in humans that is preferentially amplified in aneuploid tumors. Their combined strategy using mouse and human models identified the role of a common tumor susceptibility gene, Stk6/STK15, in promoting genetic instability although the mechanisms by which they modify risk differ between mouse and human.
58. Ota T., Suto S., Katayama H., Han Z.B., Suzuki F., Maeda M., Tanino M., Terada Y., Tatsuka M. Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res. 62:2002;5168-5177.
59. Wang X., Jin D.Y., Ng R.W., Feng H., Wong Y.C., Cheung A.L., Tsao S.W. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res. 62:2002;1662-1668.
60. Shichiri M., Yoshinaga K., Hisatomi H., Sugihara K., Hirata Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res. 62:2002;13-17.
61. Lee H. Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas. Exp Mol Med. 35:2003;448-453.
62. Lin H.R., Ting N.S., Qin J., Lee W.H. M phase-specific phosphorylation of BRCA2 by Polo-like kinase 1 correlates with the dissociation of the BRCA2-P/CAF complex. J Biol Chem. 278:2003;35979-35987.